Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine

Artemisinin derivatives and their partner drugs in artemisinin combination therapies (ACTs) have played a pivotal role in global malaria mortality reduction during the last two decades. The loss of artemisinin efficacy due to evolving drug-resistant parasites could become a serious global health thr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Parasitol Drugs Drug Resist
Main Authors: Loesbanluechai, Duangkamon, Kotanan, Namfon, de Cozar, Cristina, Kochakarn, Theerarat, Ansbro, Megan R., Chotivanich, Kesinee, White, Nicholas J., Wilairat, Prapon, Lee, Marcus C.S., Gamo, Francisco Javier, Sanz, Laura Maria, Chookajorn, Thanat, Kümpornsin, Krittikorn
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6304341/
https://ncbi.nlm.nih.gov/pubmed/30580023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2018.11.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki